Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E4P0 | ISIN: US12530C1071 | Ticker-Symbol:
NASDAQ
08.11.24
15:30 Uhr
6,730 US-Dollar
+0,030
+0,45 %
1-Jahres-Chart
CFSB BANCORP INC Chart 1 Jahr
5-Tage-Chart
CFSB BANCORP INC 5-Tage-Chart
PR Newswire
164 Leser
Artikel bewerten:
(1)

CFSB Bancorp, Inc. Announces Fiscal Third Quarter And Year-to-date 2024 Financial Results

Finanznachrichten News

QUINCY, Mass., April 29, 2024 /PRNewswire/ -- CFSB Bancorp, Inc. (the "Company") (NASDAQ Capital Market: CFSB), the holding company for Colonial Federal Savings Bank (the "Bank"), today announced a net loss of $40,000, or $0.01 per basic and diluted share, for the three months ended March 31, 2024 compared to a net loss of $210,000, or $0.03 per basic and diluted share, for the three months ended December 31, 2023 and net income of $355,000, or $0.06 per basic and diluted share, for the three months ended March 31, 2023.

For the nine months ended March 31, 2024, the net loss was $127,000, or $0.02 per basic and diluted share, compared to net income of $1.3 million, or $0.21 per basic and diluted share, for the nine months ended March 31, 2023.

Michael E. McFarland, President and Chief Executive Officer, stated, "Liabilities continue to reprice at a faster rate than assets. These short- term rates over the last twenty-four months have continued to challenge our residential and commercial lending. A slight realignment of the yield curve will assist us moving forward."

Third Quarter Operating Results
Net interest income, on a fully tax-equivalent basis, remained unchanged at $1.7 million for the three months ended March 31, 2024, and December 31, 2023. The net interest margin decreased by six basis points to 1.96% for the three months ended March 31, 2024, from 2.02% for the three months ended December 31, 2023. Net interest income reflected a $19,000 increase in interest and fees on loans, a $56,000 increase in interest and dividends on debt securities and a $127,000 increase in interest on short-term investments, offset by an increase of $146,000 in interest expense on interest-bearing deposits and a $57,000 increase in interest expense on FHLB advances. These increases were primarily due to the rising rate environment as well as increases in the average balance of cash and short-term investments of $10.4 million, or 232.51%, interest-bearing deposits of $4.1 million, or 1.8%, and FHLB advances of $5.9 million, or 70.4%, for the three months ending March 31, 2024 compared to the three months ended December 31, 2023.

Net interest income, on a fully tax-equivalent basis, decreased by $514,000, or 23.6%, to $1.7 million for the three months ended March 31, 2024, from $2.2 million for the three months ended March 31, 2023. The net interest margin decreased by 63 basis points to 1.96% for the three months ended March 31, 2024, from 2.59% for the three months ended March 31, 2023. The decline was primarily due to a 200 basis point increase in the average rate for certificates of deposit, partially offset by an $8.9 million decrease in the average balance of interest-bearing deposits and a 34 basis point increase in the average yield on interest-earning assets. The interest earned on loans increased $77,000, to $1.8 million for the three months ended March 31, 2024, from $1.7 million for the three months ended March 31, 2023. The interest earned on securities increased $116,000, to $1.1 million for the three months ended March 31, 2024, from $938,000 for the three months ended March 31, 2023. The interest earned on cash and short-term investments increased $123,000, to $176,000 for the three months ended March 31, 2024, from $53,000 for the three months ended March 31, 2023. The interest earned on interest-earning assets was due to higher average cash balances as well as rising interest rates.

The Company recorded reversals of the provision for credit losses of $20,000 and $104,000 for the three months ended March 31, 2024 and December 31, 2023, respectively. The reversals of the provision for credit losses were recorded due to improved forecasted economic conditions, lower loan balances and continued strong asset quality. The Company did not record a provision for loan losses during the three months ended March 31, 2023. The allowance for credit losses as a percentage of total loans was 0.90%, 0.93% and 0.98% at March 31, 2024, December 31, 2023 and March 31, 2023, respectively.

Non-interest income decreased $5,000, or 2.9%, to $167,000 for the three months ended March 31, 2024, from $172,000 for the three months ended December 31, 2023, primarily due to a decrease of $8,000 in other income, offset by an increase of $4,000 in customer service fees.

Non-interest income increased $19,000, or 12.8%, to $167,000 for the three months ended March 31, 2024, from $148,000 for the three months ended March 31, 2023, primarily due to an increase in customer service fees of $4,000, or 10.8%, and an increase in other income of $12,000, or 25.5%.

Non-interest expense decreased $201,000, or 9.5%, to $1.9 million for the three months ended March 31, 2024, from $2.1 million for the three months ended December 31, 2023. The decrease was due to a decrease in salaries and employee benefits of $150,000, or 11.8%, due to a reduced headcount and a decrease in other general and administrative expenses of $59,000, or 13.7%, primarily due to decreases in printing, legal and annual meeting expenses.

Non-interest expense increased $7,000, or 0.4%, to $1.9 million for the three months ended March 31, 2024, from the three months ended March 31, 2023. The increase was primarily due to an increase in salaries and employee benefits of $14,000, or 1.3%, an increase in data processing expense of $13,000, or 15.5%, and an increase in deposit insurance of $13,000, or 65.0%, offset by decreases in advertising expense of $6,000, or 15.8%, and other general and administrative expenses of $27,000, or 6.8%, primarily due to decreases in printing, legal and annual meeting expenses, offset by costs associated with director's stock-based compensation.

The Company recorded an income tax benefit of $42,000 for the three months ended March 31, 2024, compared to a provision for income taxes of $16,000 for the three months ended December 31, 2023 and $47,000 for the three months ended March 31, 2023. The decrease in income tax expense for the three months ended March 31, 2024, compared to the three months ended December 31, 2023 was due to the absence of adjustments to deferred taxes and the valuation allowance of deferred taxes. The decrease in income tax expense for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, was due to a decrease in income before income taxes.

Year-to-Date Operating Results
Net interest income decreased, on a fully tax-equivalent basis, by $1.8 million, or 25.7%, to $5.2 million for the nine months ended March 31, 2024, from $6.9 million for the nine months ended March 31, 2023, due to a $2.3 million increase in interest expense due to an increase in the interest on certificates of deposit of $2.1 million and the increase in interest on FHLB Advances of $332,000 from the prior year. The Company recognized a 132 basis point increase in the cost of interest-bearing liabilities, due to higher interest rates and a greater percentage of interest-bearing liabilities in higher-costing certificates of deposit and borrowings. The increase in interest expense was offset by an increase in interest income of $556,000 due to higher average yields on loans, securities and cash and short-term investments. A 25 basis point increase in the average yield on loans, offset by a decrease in the average balance of loans of $1.9 million, or 1.09%, contributed to a $281,000 increase in loan income. A 29 basis point increase in the average yield on securities, offset by a decrease in the average balance of securities of $1.0 million, or 0.7%, contributed to a $308,000 increase in securities income. The interest earned on cash and short-term investments decreased $33,000 from the prior year, due to a $5.7 million decrease in the average balance of cash and short-term investments offset by a 166 basis point increase in the average yield. The net interest margin decreased 65 basis points for the nine months ended March 31, 2024, to 2.06%, from 2.71% in the prior year period.

The Company recognized a reversal of the provision for credit losses of $290,000 for the nine months ended March 31, 2024, compared to no provision for loan losses in the prior year period. The reversal of the provision for credit losses for the nine months ended March 31, 2024 was recorded due to improved forecasted economic conditions, lower loan balances and continued strong asset quality.

Non-interest income decreased $1,000, or 0.2%, to $499,000 for the nine months ended March 31, 2024, from $500,000 for the nine months ended March 31, 2023. The decrease was primarily due to a decrease of $19,000 in safe deposit box fees as we now recognize fees over the rental period, offset by increases in customer service fees of $8,000 and income on bank-owned life insurance of $10,000.

Non-interest expenses increased $197,000, or 3.4%, to $5.9 million for the nine months ended March 31, 2024, from $5.7 million for the nine months ended March 31, 2023. Salaries and benefits increased $157,000, or 4.7%, to $3.5 million, due to annual increases to salaries and health insurance of employees and employee stock-based compensation expense, deposit insurance increased $36,000, data processing costs increased $25,000 and other general and administrative expenses increased $25,000, offset by a $42,000 decrease in advertising costs.

Income tax expense decreased $215,000 to $67,000 for the nine months ended March 31, 2024, compared to income tax expense of $282,000 for the nine months ended March 31, 2023, due to the decrease in income before income taxes, partially offset by an increase in the deferred tax valuation allowance.

Balance Sheet
Assets: At March 31, 2024, total assets amounted to $358.1 million, compared to $349.0 million at June 30, 2023, an increase of $9.1 million, or 2.6%, due to a $14.8 million increase in cash and cash equivalents, a $346,000 increase in prepaid items and a $323,000 increase in FHLB of Boston (FHLBB) stock, offset by a $5.0 million decrease in net loans and a $1.4 million decrease in securities. The increase in cash and cash equivalents was due to increases in deposits and FHLBB advances, and decreases in loans was a result of borrower principal payments exceeding new origination, due to the higher interest rate environment.

Asset Quality: At March 31, 2024, there were four current loans rated substandard with a provision for credit loss of $1,000 and no loans rated special mention, doubtful or loss. The reversal of the provision for credit losses for the three and nine months ended March 31, 2024 reflected continued strong asset quality

Liabilities: Deposits increased by $2.3 million, or 0.9%, during the nine months ended March 31, 2024, due to increases in higher-yielding term certificates. FHLBB advances were $10.4 million at March 31, 2024 compared to $3.7 million at June 30, 2023, as we implemented a leverage strategy that increased liquidity and interest income.

Stockholders' Equity. Total stockholders' equity decreased $27,000, to $75.9 million at March 31, 2024, from June 30, 2023. The decrease was primarily due to the net loss of $127,000 and the effect of the adoption of ASU 2016-13, net of taxes, of $223,000, offset by the change in unearned ESOP compensation of $77,000, and stock-based compensation of $269,000, for the nine months ended March 31, 2024.

On July 1, 2023, the Company adopted ASU 2016-13, which replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss ("CECL") methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loans receivable and securities held to maturity. In addition, ASC 326 made changes to the accounting for securities available for sale. It also applies to off-balance sheet credit exposures not accounted for as insurance, such as loan commitments, standby letters of credit, financial guarantees, and other similar instruments. The following table illustrates the impact of ASC 326:



Pre-ASC Adoption



As Reported Under ASC 326





(In thousands)


June 30, 2023



July 1, 2023



Impact of ASC 326 Adoption


Assets










Allowance for credit losses on
securities held to maturity


$

-



$

(276)



$

(276)


Allowance for credit losses on loans



(1,747)




(1,759)




(12)


Deferred tax asset on allowance for
credit losses



466




378




(88)












Liabilities










Allowance for credit losses on off-
balance sheet exposures


$

-



$

23



$

23












Shareholders' Equity










Retained earnings


$

50,416



$

50,193



$

(223)


About CFSB Bancorp, Inc.
CFSB Bancorp, Inc. is the federal mid-tier holding company of Colonial Federal Savings Bank and is the majority-owned subsidiary of 15 Beach, MHC. Colonial Federal Savings Bank is a federally chartered stock savings bank that has served the banking needs of its customers on the south shore of Massachusetts since 1889. It operates from three full-service offices and one limited-service office in Quincy, Holbrook and Weymouth, Massachusetts.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, which can be identified by the use of words such as "estimate," "project," "believe," "intend," "anticipate," "assume," "plan," "seek," "expect," "will," "may," "should," "indicate," "would," "contemplate," "continue," "target" and words of similar meaning. These forward-looking statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Certain factors that could cause actual results to differ materially from expected results include increased competitive pressures, demand for loan products, deposit flows, changes in the interest rate environment, the effects of inflation, potential recessionary conditions, general economic conditions or conditions within the securities markets, monetary and fiscal policies of the U.S. Government, including policies of the U.S. Treasury and the Board of Governors of the FRB, changes in the quality, size and composition of our loan and securities portfolios, changes in liquidity, including the size and composition of our deposit portfolio, including the percentage of uninsured deposits in the portfolio; changes in asset quality, prepayment speeds, charge-offs and/or credit loss provisions, our ability to access cost-effective funding; changes in demand for our products and services, legislative, accounting, tax and regulatory changes, the current or anticipated impact of military conflict, terrorism or other geopolitical events, a failure in or breach of our operational or security systems or infrastructure, including cyberattacks that could adversely affect the Company's financial condition and results of operations and the business in which the Company and the Bank are engaged, the failure to maintain current technologies and the failure to retain or attract employees.

You should not place undue reliance on forward-looking statements. CFSB Bancorp, Inc. undertakes no obligation to revise these forward-looking statements or to reflect events or circumstances after the date of this press release.

CFSB Bancorp, Inc. and Subsidiary

Consolidated Balance Sheets (Unaudited)

(In thousands, except per share data)










March 31,



June 30,




2024



2023


Assets:







Cash and due from banks


$

1,182



$

1,486


Short-term investments



20,482




5,375


Total cash and cash equivalents



21,664




6,861


Securities available for sale, at fair value



119




146


Securities held to maturity, at amortized cost, net of allowance for credit losses



146,463




147,902


Loans:







1-4 family



136,430




140,109


Multifamily



11,854




12,638


Second mortgages and home equity lines of credit



3,495




2,699


Construction



-




-


Commercial



18,852




20,323


Total mortgage loans on real estate



170,631




175,769


Consumer



89




49


Home improvement



2,128




2,191


Total loans



172,848




178,009


Allowance for credit losses



(1,561)




(1,747)


Net deferred loan costs and fees, and purchase premiums



(399)




(351)


Loans, net



170,888




175,911


Federal Home Loan Bank of Boston stock, at cost



704




381


Premises and equipment, net



3,267




3,413


Accrued interest receivable



1,400




1,363


Bank-owned life insurance



10,603




10,402


Deferred tax asset



1,129




1,079


Operating lease right of use asset



884




953


Other assets



943




596


Total assets


$

358,064



$

349,007









Liabilities and Stockholders' Equity:







Deposits:







Non-interest bearing NOW and demand


$

30,789



$

32,760


Interest bearing NOW and demand



28,859




28,778


Regular and other



56,118




64,184


Money market accounts



22,872




26,995


Term certificates



127,000




110,659


Total deposits



265,638




263,376


Federal Home Loan Bank of Boston advances



10,350




3,675


Mortgagors' escrow accounts



1,526




1,596


Operating lease liability



898




962


Accrued expenses and other liabilities



3,790




3,509


Total liabilities



282,202




273,118









Stockholders' Equity:







Common stock



65




65


Additional paid-in capital



28,058




27,814


Retained earnings



50,066




50,416


Accumulated other comprehensive loss, net of tax



(1)




(3)


Unearned compensation - ESOP



(2,326)




(2,403)


Total stockholders' equity



75,862




75,889


Total liabilities and stockholders' equity


$

358,064



$

349,007


CFSB Bancorp, Inc. and Subsidiary

Consolidated Statements of Net Income (Loss) (Unaudited)

(In thousands, except per share data)










For the Three Months Ended



For the Nine Months Ended




March 31,



December 31,



March 31,



March 31,



March 31,




2024



2023



2023



2024



2023


Interest and dividend income:
















Interest and fees on loans


$

1,777



$

1,758



$

1,700



$

5,257



$

4,976


Interest and dividends on debt securities:
















Taxable



965




904




837




2,737




2,383


Tax-exempt



89




93




101




279




315


Interest on short-term investments



176




49




53




270




303


Total interest and dividend income



3,007




2,804




2,691




8,543




7,977


















Interest expense:
















Deposits



1,197




1,051




533




3,124




1,115


Borrowings



171




114




3




335




3


Total interest expense



1,368




1,165




536




3,459




1,118


















Net interest income



1,639




1,639




2,155




5,084




6,859


Provision for (reversal of) credit losses



(20)




(104)




-




(290)




-


Net interest income after provision for (reversal of) credit losses



1,659




1,743




2,155




5,374




6,859


















Non-interest income:
















Customer service fees



41




37




37




118




110


Income on bank-owned life insurance



67




68




64




201




191


Other income



59




67




47




180




199


Total non-interest income



167




172




148




499




500


















Non-interest expenses:
















Salaries and employee benefits



1,117




1,267




1,103




3,528




3,371


Occupancy and equipment



256




240




256




750




754


Advertising



32




36




38




106




148


Data processing



97




101




84




287




262


Deposit insurance



33




33




20




99




63


Other general and administrative



373




432




400




1,163




1,138


Total non-interest expenses



1,908




2,109




1,901




5,933




5,736


















Income (loss) before income taxes



(82)




(194)




402




(60)




1,623


Provision (benefit) for income taxes



(42)




16




47




67




282


Net income (loss)


$

(40)



$

(210)



$

355



$

(127)



$

1,341


















Net income (loss) per share:
















Basic


$

(0.01)



$

(0.03)



$

0.06



$

(0.02)



$

0.21


Diluted


$

(0.01)



$

(0.03)



$

0.06



$

(0.02)



$

0.21


















Weighted average shares outstanding:
















Basic



6,292,060




6,284,768




6,300,633




6,286,323




6,282,384


Diluted



6,292,060




6,284,768




6,300,721




6,286,323




6,282,413


CFSB Bancorp, Inc. and Subsidiary

Average Balances and Yields, Fully Tax-Equivalent Basis (Unaudited)

(Dollars in thousands)





Average Balance and Yields



Three Months Ended



March 31, 2024



December 31, 2023



March 31, 2023



Average



Interest



Average



Average



Interest



Average



Average



Interest



Average



Outstanding



Earned/



Yield/



Outstanding



Earned/



Yield/



Outstanding



Earned/



Yield/


(Dollars in thousands)

Balance



Paid



Rate



Balance



Paid



Rate



Balance



Paid



Rate


Interest-earning assets:



























Loans

$

175,072



$

1,777




4.06

%


$

176,149



$

1,758




3.99

%


$

179,452



$

1,700




3.79

%

Securities (1)


149,442




1,078




2.89

%



149,187




1,022




2.74

%



150,945




960




2.54

%

Cash and short-term investments


14,933




176




4.71

%



4,491




49




4.36

%



5,287




53




4.01

%

Total interest-earning assets


339,447




3,031




3.57

%



329,827




2,829




3.43

%



335,684




2,713




3.23

%

Noninterest-earning assets


17,082










16,875










17,207








Total assets

$

356,529









$

346,702









$

352,891








Interest-bearing liabilities:



























Interest-bearing demand deposits

$

30,261



$

4




0.05

%


$

29,746



$

4




0.05

%


$

32,245



$

4




0.05

%

Savings deposits


57,619




14




0.10

%



58,992




15




0.10

%



68,097




17




0.10

%

Money market deposits


23,396




15




0.26

%



24,153




15




0.25

%



34,377




22




0.26

%

Certificates of deposit


121,108




1,164




3.84

%



115,397




1,017




3.53

%



106,555




490




1.84

%

Total interest-bearing deposits


232,384




1,197




2.06

%



228,288




1,051




1.84

%



241,274




533




0.88

%

FHLB advances


14,186




171




4.82

%



8,323




114




5.48

%



244




3




4.92

%

Total interest-bearing liabilities


246,570




1,368




2.22

%



236,611




1,165




1.97

%



241,518




536




0.89

%

Noninterest-bearing liabilities:



























Noninterest-bearing demand deposits


28,530










28,223










30,352








Other noninterest-bearing liabilities


5,650










5,968










5,554








Total liabilities


280,750










270,802










277,424








Total stockholders' equity


75,779










75,900










75,467








Total liabilities and stockholders' equity

$

356,529









$

346,702









$

352,891








Net interest income




$

1,663









$

1,664









$

2,177





Net interest rate spread(2)








1.35

%









1.46

%









2.34

%

Net interest-earning assets(3)

$

92,877









$

93,216









$

94,166








Net interest margin(4)








1.96

%









2.02

%









2.59

%

Cost of deposits(5)








1.84

%









1.64

%









0.78

%

Cost of funds(6)








1.99

%









1.76

%









0.79

%

Ratio of interest-earning assets to interest-bearing liabilities


137.67

%









139.40

%









138.99

%







(1) Includes tax equivalent adjustments for municipal securities, based on a statutory tax rate of 21%, of $24,000, $25,000, and $22,000 for the three months ended March 31, 2024, December 31, 2023 and March 31, 2023, respectively.

(2) Net interest rate spread represents the difference between the weighted average yield earned on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.

(3) Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities.

(4) Net interest margin represents net interest income divided by average total interest-earning assets.

(5) Cost of deposits represents the total interest paid on deposits, divided by total interest-bearing deposits plus total noninterest-bearing deposits.

(6) Cost of funds represents the total interest paid on liabilities, divided by total interest-bearing liabilities plus total noninterest-bearing deposits.

CFSB Bancorp, Inc. and Subsidiary

Average Balances and Yields, Fully Tax-Equivalent Basis (Unaudited)

(Dollars in thousands)





Average Balance and Yields



Nine Months Ended



March 31, 2024



March 31, 2023



Average



Interest



Average



Average



Interest



Average



Outstanding



Earned/



Yield/



Outstanding



Earned/



Yield/


(Dollars in thousands)

Balance



Paid



Rate



Balance



Paid



Rate


Interest-earning assets:


















Loans

$

175,966



$

5,257




3.98

%


$

177,898



$

4,976




3.73

%

Securities (1)


149,296




3,090




2.76

%



150,318




2,782




2.47

%

Cash and short-term investments


7,733




270




4.66

%



13,445




303




3.00

%

Total interest-earning assets


332,995




8,617




3.45

%



341,661




8,061




3.15

%

Noninterest-earning assets


16,765










16,401








Total assets

$

349,760









$

358,062








Interest-bearing liabilities:


















Interest-bearing demand deposits

$

29,972



$

11




0.05

%


$

32,982



$

12




0.05

%

Savings deposits


59,693




47




0.10

%



72,112




54




0.10

%

Money market deposits


24,611




45




0.24

%



39,956




80




0.27

%

Certificates of deposit


116,087




3,021




3.47

%



100,875




969




1.28

%

Total interest-bearing deposits


230,363




3,124




1.81

%



245,925




1,115




0.60

%

FHLB advances


8,673




335




5.15

%



80




3




5.00

%

Total interest-bearing liabilities


239,036




3,459




1.93

%



246,005




1,118




0.61

%

Noninterest-bearing liabilities:


















Noninterest-bearing demand deposits


29,244










31,928








Other noninterest-bearing liabilities


5,683










5,044








Total liabilities


273,963










282,977








Total stockholders' equity


75,797










75,085








Total liabilities and stockholders' equity

$

349,760









$

358,062








Net interest income




$

5,158









$

6,943





Net interest rate spread(2)








1.52

%









2.54

%

Net interest-earning assets(3)

$

93,959









$

95,656








Net interest margin(4)








2.07

%









2.71

%

Cost of deposits(5)








1.60

%









0.54

%

Cost of funds(6)








1.72

%









0.54

%

Ratio of interest-earning assets to interest-bearing liabilities


139.31

%









138.88

%







(1) Includes tax equivalent adjustments for municipal securities, based on a statutory tax rate of 21%, of $74,000 and $84,000 for the nine months ended March 31, 2024 and March 31, 2023, respectively.

(2) Net interest rate spread represents the difference between the weighted average yield earned on interest-earning assets and the weighted average rate paid on interest-bearing liabilities.

(3) Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities.

(4) Net interest margin represents net interest income divided by average total interest-earning assets.

(5) Cost of deposits represents the total interest paid on deposits, divided by total interest-bearing deposits plus total noninterest-bearing deposits.

(6) Cost of funds represents the total interest paid on liabilities, divided by total interest-bearing liabilities plus total noninterest-bearing deposits.


CFSB Bancorp, Inc. and Subsidiary

Reconciliation of Fully Tax-Equivalent Income (Unaudited)

(In thousands)










For the Three Months Ended



For the Nine Months Ended




March 31,



December 31,



March 31,



March 31,



March 31,




2024



2023



2023



2024



2023


Securities interest income (no tax adjustment)


$

1,054



$

997



$

938



$

3,016



$

2,698


Tax-equivalent adjustment



24




25




22




74




84


Securities (tax-equivalent basis)


$

1,078



$

1,022



$

960



$

3,090



$

2,782


Net interest income (no tax adjustment)


$

1,639



$

1,639



$

2,155



$

5,084




6,859


Tax-equivalent adjustment



24




25




22




74




84


Net interest income (tax-equivalent adjustment)


$

1,663



$

1,664



$

2,177



$

5,158



$

6,943


CFSB Bancorp, Inc. and Subsidiary


At or for the Three Months Ended



At or for the Nine Months Ended


Selected Financial Highlights (Unaudited)


March 31,



December 31,



March 31,



March 31,



March 31,


(In thousands, except share and per share amounts)


2024



2023



2023



2024



2023


Performance Ratios
















Return (loss) on average assets (GAAP) (1, 4)



(0.04)

%



(0.24)

%



0.40

%



(0.05)

%



0.50

%

Return (loss) on average equity ("ROAE") (GAAP) (1, 5)



(0.21)

%



(1.11)

%



1.88

%



(0.22)

%



2.38

%

Noninterest expense to average assets (GAAP) (1)



2.14

%



2.43

%



2.15

%



2.43

%



2.14

%

Total loans to total deposits



65.07

%



68.62

%



66.32

%



65.07

%



66.32

%

Total loans to total assets



48.27

%



49.30

%



50.92

%



48.27

%



50.92

%

Efficiency ratio (GAAP) (6)



105.65

%



116.45

%



82.54

%



106.27

%



77.95

%

Capital Ratios
















Total capital to risk-weighted assets



34.07

%



33.32

%



32.60

%



34.07

%



32.60

%

Common equity tier 1 capital to risk-weighted assets



33.15

%



32.41

%



31.70

%



33.15

%



31.70

%

Tier 1 capital to risk-weighted assets



33.15

%



32.41

%



31.70

%



33.15

%



31.70

%

Tier 1 capital to average assets (2)



17.83

%



18.32

%



17.90

%



17.83

%



17.90

%

Asset Quality Ratios
















Allowance for credit losses on loans as a percentage of total loans (3)



0.90

%



0.93

%



0.98

%



0.90

%



0.98

%

Allowance for credit losses on loans as a percentage of non-performing loans


NM




1740.46

%


NM



NM



NM


Net (charge-offs) recoveries to average outstanding loans



-

%



-

%



-

%



-

%



-

%

Non-performing loans as a percentage of total loans



-

%



0.05

%



-

%



-

%



-

%

Non-performing loans as a percentage of total assets



-

%



0.03

%



-

%



-

%



-

%

Informational Items
















Fair value of held to maturity securities


$

132,946



$

136,427



$

136,774



$

132,946



$

136,774


Book value per share (7)


$

11.44



$

11.43



$

11.41



$

11.44



$

11.41


Outstanding common shares



6,632,642




6,632,642




6,632,642




6,632,642




6,632,642


(1) Annualized.

(2) Average assets calculated on a quarterly basis.

(3) Total loans exclude net deferred loan costs and fees.

(4) Represents net income divided by average assets.

(5) Represents net income divided by average stockholders' equity

(6) Represents total non-interest expenses divided by net interest income and non-interest income.

(7) Represents total stockholders' equity divided by outstanding shares at period end.

SOURCE CFSB Bancorp, Inc.

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.